Research Paper
Regulation of bone and fat balance by fructus ligustri lucidi in ovariectomized mice
- 1 Tianjin University of Traditional Chinese Medicine, Tianjin, China
- 2 Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
Received: March 11, 2021 Accepted: August 24, 2021
https://doi.org/10.18632/aging.How to Cite
Copyright: © 2021 Qin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Fructus Ligustri Lucidi, a traditional Chinese medicine, is the fruit of Ligustrum lucidum Ait. (Oleaceae). It has invigorating effects on the liver and kidneys and is a commonly used herb in the treatment of age-related diseases. The ethanol extract of FLL is a potential candidate for the prevention and treatment of postmenopausal osteoporosis. In the present study, we aimed to determine whether the ethanol extract of FLL wields an anti-osteoporotic effect on ovariectomized mice and to explore the relevant underlying mechanisms of action. One week after surgery, animals were randomly assigned to five groups, at 10 per group: a sham group, OVX group, E2 group, and FLL group (2 g/kg and 4 g/kg). Eight weeks after treatment, we harvested the uteri, femurs, tibias, visceral organs, and plasma from the mice. The levels of estradiol, Trap, Trap5b, OPG, and RANKL in plasma were determined by ELISA. We assessed bone mineral density and bone microstructure by X-ray absorptiometry and micro-CT, and the formation of F-actin rings was detected by immunofluorescence staining assay. FLL significantly decreased osteoclast activity, increased bone mineral density, and improved bone microstructure in OVX mice (P < 0.05). The fat content of abdominal fat and bone marrow were also reduced after treatment with FLL (P < 0.01). In addition, FLL (1 μg/mL) suppressed the formation of osteoclasts and F-actin rings in vitro (P < 0.01). FLL inhibited adipocyte differentiation in both fate determination and maturation from monocytes by inhibiting Zfp423 and PPARγ mRNAs (P < 0.01 or P < 0.05). In summary, FLL prevented additional bone loss and improved bone microstructure in OVX mice by suppressing the activity of osteoclasts and reducing the fat content in the abdomen and the bone marrow.
Abbreviations
ACP5: acid phosphatase 5; ALP: alkaline phosphatase; BMD: bone mineral density; BMMSCs: bone marrow mesenchymal stem cells; BSA: bovine serum albumin; CCK-8: Cell Counting Kit-8; Conn.D: connectivity density; E2: estrogen; ELISA: enzyme-linked immunosorbent assay; FBS: fetal bovine serum; FLL: Fructus Ligustri Lucidi; M-CSF: macrophage colony-stimulating factor; NFATC1: nuclear factor of activated T cells 1; OPG: osteoprotegerin; OVX: ovariectomy; PBS: phosphate-buffered saline; PCR: polymerase chain reaction; PMOP: postmenopausal osteoporosis; PPAR: peroxisome proliferator-activated receptor gamma; RANKL: receptor activator of NF-kB ligand; RUNX2: RUNX family transcription factor 2; TCM: traditional Chinese medicine; Trap: tartrate- resistant acid phosphatase; Trap5b: tartrate-resistant acid phosphatase 5b; VAT: visceral adipose tissue; Zfp423: zinc-finger protein 423.